Earnings Call · Q2 FY2021·2021-08-16

Q2 21EPS -26.74%·Rev n/aQ1 21EPS -33.85%·Rev n/aQ4 20EPS -100.00%*·Rev n/aQ3 20EPS -100.00%*·Rev n/a⚠ consensus missing

Taysha Gene Therapies, Inc. TSHA

Kimberly Lee — Senior Vice President of Corporate Communications

Suyash Prasad — Chief Medical Officer and Head of R&D

Kamran Alam — Chief Financial Officer

−9.0%1d on move date−9.2% vs SPY3d−2.2%5d−2.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TSHA calls or request research access.

More TSHA calls Browse calls Request research access